Nancy Miller-Rich

Nancy Miller-Rich

DirectoratAldeyra Therapeutics· In proxies 2023–2025

Nancy Miller-Rich sits on 3 public boards.

Boards1

  • Aldeyra TherapeuticsDirector · 5 yr on the boardIndependentCompensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Aldeyra TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -90%
  2. Intercept Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Kadmon HoldingsPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?